At the same time, NSE level was significantly down‐regulated in MS in comparison to CC4, 21.3 ng/ml vs 24 ng/ml, (P = 0.0116, <0.05), (Figure 3). The gene discussed is ENO2; the disease is myeloid sarcoma.